Relay Therapeutics, Inc.
RLAY
$7.79
$0.304.01%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.84% | 23.68% | 5.31% | 8.97% | -34.03% |
| Total Depreciation and Amortization | -45.28% | -26.75% | -13.41% | -2.98% | 0.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -23.45% | 31.68% | -18.27% | 13.47% | 8.71% |
| Change in Net Operating Assets | 54.29% | -114.86% | -289.03% | 107.03% | 73.42% |
| Cash from Operations | 17.27% | 16.06% | -45.48% | 35.12% | 0.42% |
| Capital Expenditure | 100.44% | -136.36% | 78.43% | 100.00% | 61.53% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 131.54% | 64.99% | 248.05% | -51.51% | -275.02% |
| Cash from Investing | 131.49% | 64.97% | 303.24% | -51.41% | -276.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.99% | -57.65% | -- | -96.35% | 2,214.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.99% | -57.65% | -- | -96.35% | 2,214.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -226.82% | 209.59% | -436.75% | -269.73% | 225.18% |